Prevalence, risk factors and molecular epidemiology of methicillin- resistant Staphylococcus aureus (MRSA) colonization in residents of long-term care facilities in Luxembourg, 2010

Epidemiology and Infection

Volumn 141, Issue 6, 2013, Pages 1199-1206

  Mossong, J ^a   Gelhausen, E ^b   Decruyenaere, F ^a   Devaux, A ^a   Perrin, M ^a   Even, J ^a   Heisbourg, E ^b  

^a National Public Health Laboratory Luxembourg   (Luxembourg)

^b Health Directorate   (Luxembourg)

Author keywords

Antibiotic resistance; antimicrobial resistance in agricultural settings; hospital acquired (nosocomial) infections; methicillin resistant S. aureus (MRSA); molecular epidemiology

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; FURAN DERIVATIVE; GENTAMICIN; KANAMYCIN; PENICILLIN DERIVATIVE; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INFECTION RISK; LUXEMBOURG; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; NURSING HOME PATIENT; PREVALENCE; RISK FACTOR;

AGED; ANTI-BACTERIAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HUMANS; LOGISTIC MODELS; LONG-TERM CARE; LUXEMBOURG; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; ODDS RATIO; PREVALENCE; QUINOLONES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS;

EID: 84876945793     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001999     Document Type: Article

References (30)

1. Kock R, et al. Methicillin-resistant Staphylococcus aur-eus (MRSA): burden of disease and control challenges in Europe. Eurosurveillance 2010; 15: 19688.
2. Manzur A, Gudiol F. Methicillin-resistant Staphylococ-cus aureus in long-term-care facilities. Clinical Microbiology and Infection 2009; 15 (Suppl. 7): 26-30.
3. Manzur A, et al. Clinical significance of methicillin-re-sistant Staphylococcus aureus colonization in residents in community long-term-care facilities in Spain. Epidemiology and Infection 2012; 140: 400-406.
4. Daeschlein G, et al. Risk factors for Staphylococcus aureus nasal carriage in residents of three nursing homes in Germany. Journal of Hospital Infection 2006; 63: 216-220.
5. von Baum H, et al. Risk factors for methicillin-resistant Staphylococcus aureus carriage in residents of German nursing homes. Infection Control and Hospital Epidemiology 2002; 23: 511-515.
6. Woltering R, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in patients in long-term care in hospitals, rehabilitation centers and nursing homes of a rural district in Germany. Deutsche Medizinische Wochenschrift 2008; 133: 999-1003.
7. Neuhaus B, et al. Survey of methicillin-resistant Staphylococcus aureus in long-term facilities for the aged in Northrhine Westphalia. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2002; 45: 898-904.
8. Suetens C, et al. Determinants of methicillin-resistant Staphylococcus aureus carriage in nursing homes. Age and Ageing 2007; 36: 327-330.
9. Pfingsten-Wurzburg S, et al. Prevalence and molecular epidemiology of meticillin-resistant Staphylococcus aureus in nursing home residents in northern Germany. Journal of Hospital Infection 2011; 78: 108-112.
10. Brugnaro P, et al. Clustering and risk factors of methi-cillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection 2009; 37: 216-221.
11. Lasseter G, et al. Staphylococcus aureus carriage in care homes: identification of risk factors, including the role of dementia. Epidemiology and Infection 2010; 138: 686-696.
12. Vovko P, et al. Risk factors for colonization with me-thicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infection Control and Hospital Epidemiology 2005; 26: 191-195.
13. Manzur A, et al. Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain. Clinical Microbiology and Infection 2008; 14: 867-872.
14. Denis O, et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. Journal of Antimicrobial Chemotherapy 2009; 64: 1299-1306.
15. Barr B, et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization among older residents of care homes in the United Kingdom. Infection Control and Hospital Epidemiology 2007; 28: 853-859.
16. Eveillard M, et al. Methicillin-resistant Staphylococcus aureus carriage in a long-term care facility: hypothesis about selection and transmission. Age and Ageing 2008; 37: 294-299.
17. Oliveira DC, et al. Comparison of DNA sequencing of the protein A gene polymorphic region with other molecular typing techniques for typing two epidemio-logically diverse collections of methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 2001; 39: 574-580.
18. Koreen L, et al. spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro-and macrovariation. Journal of Clinical Microbiology 2004; 42: 792-799.
19. Baum C, et al. Non-spa-typeable clinical Staphylococcus aureus strains are naturally occurring protein A mutants. Journal of Clinical Microbiology 2009; 47: 3624-3629.
20. Enright MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008-1015.
21. Dulon M, et al. MRSA prevalence in European healthcare settings: a review. BMC Infectious Diseases 2011; 11: 138.
22. Ribbe MW, et al. Nursing homes in 10 nations: a comparison between countries and settings. Age and Ageing 1997; 26 (Suppl. 2): 3-12.
23. Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 2007; 13: 222-235.
24. Wolters M, et al. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages. International Journal of Medical Microbiology 2011; 301: 64-68.
25. Schuh D. Using spa-typing to study MRSA isolated in the Grand-Duchy of Luxembourg [in French]. Liege, Belgium: Haute ecole Mosane d'enseignment superieur, 2006.
26. Nubel U, et al. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathogens 2010; 6: e1000855.
27. Grundmann H, et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Medicine 2010; 7: e1000215.
28. van Loo I, et al. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerging Infectious Diseases 2007; 13: 1834-1839.
29. Waters AE, et al. Multidrug-resistant Staphylococcus aureus in US meat and poultry. Clinical Infectious Diseases 2011; 52: 1227-1230.
30. Harris SR, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010; 327: 469-474.